TREATMENT OF CANCER BY SYSTEMIC ADMINISTRATION OF DBAIT MOLECULES

The present invention relates to the use of a DBait molecules by systemic routes without any combination with an endosomolytic agent. 本发明涉及DBait分子的用途,其不与任何内涵体裂解剂相组合,通过全身性途径使用。

Saved in:
Bibliographic Details
Main Authors BERTHAULT NATHALIE, DUTREIX MARIE
Format Patent
LanguageChinese
English
Published 21.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of a DBait molecules by systemic routes without any combination with an endosomolytic agent. 本发明涉及DBait分子的用途,其不与任何内涵体裂解剂相组合,通过全身性途径使用。
Bibliography:Application Number: CN201780014979